Lutein effect on retina and hippocampus of diabetic mice

Free Radical Biology and Medicine

Volumn 41, Issue 6, 2006, Pages 979-984

  Muriach, María ^a   Bosch Morell, Francisco ^a,b   Alexander, George ^c   Blomhoff, Rune ^c   Barcia, Jorge ^a   Arnal, Emma ^a   Almansa, Inma ^a   Romero, Francisco J ^a,b   Miranda, María ^a  

^a UNIVERSIDAD CEU CARDENAL HERRERA   (Spain)

^b Fundacion Oftalmologica del Mediterraneo   (Spain)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Diabetes; Hippocampus; Lutein; Oxidative stress; Retina

Indexed keywords

ALLOXAN; GLUCOSE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HEMOGLOBIN A1C; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; MALONALDEHYDE; XANTHOPHYLL;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD GLUCOSE MONITORING; CONTROLLED STUDY; DIABETES CONTROL; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DISEASE MARKER; ELECTRORETINOGRAM; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HIPPOCAMPUS; MALE; MAZE TEST; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RETINA CELL; SPECIES COMPARISON;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; ELECTRORETINOGRAPHY; GLUTATHIONE; HIPPOCAMPUS; LUTEIN; MALE; MALONDIALDEHYDE; MAZE LEARNING; MICE; NF-KAPPA B; REFERENCE VALUES; RETINA;

ANIMALIA;

EID: 33747361275     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2006.06.023     Document Type: Article

References (30)

1. Baynes J.W., and Thorpe S.R. The role of oxidative stress in diabetic complications. Curr. Opin. Endocrinol. 3 (1996) 277-284
2. Baynes J.W., and Thorpe S.R. Role of oxidatives stress in diabetic complications. A new perspective on an old paradigm. Diabetes 48 (1999) 1-9
3. Packer L., Kraemer K., and Rimbach G. Molecular aspects of lipoic acid in the prevention of diabetic complications. Nutrition 17 (2001) 888-895
4. Bonnefont-Rousselot D. Glucose and reactive oxygen species. Curr. Opin. Clin. Nutr. Metab. Care 5 (2002) 561-568
5. Kowluru R.A., Koppolu P., Chakrabarti S., and Chen S. Diabetes-induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants. Free Radical Res. 37 (2003) 1169-1180
6. Grossman H. Does diabetes protect or provoke Alzheimer's disease? Insights into the pathobiology and future treatment of Alzheimer's disease. CNS Spectr. 8 (2003) 815-823
7. Convit A., Wolf O.T., Tarshish C., and de Leon M.J. Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 2019-2022
8. Baydas G., Reiter R.J., Yasar A., Tuzcu M., Akdemir I., and Nedzvetskii V.S. Melatonin reduces glial reactivity in the hippocampus, cortex, and cerebellum of streptozotocin-induced diabetic rats. Free Radical Biol. Med. 35 (2003) 797-804
9. Li Z.G., and Sima A.A. C-peptide and central nervous system complications in diabetes. Exp. Diab. Res. 5 (2004) 79-90
10. Aragno M., Mastrocola R., Brignardello E., Catalano M., Robino G., Manti R., Parola M., Danni O., and Boccuzzi G. Dehydroepiandrosterone modulates nuclear factor-kappaB activation in hippocampus of diabetic rats. Endocrinology 143 (2002) 3250-3258
11. Trautner C., Haastert B., Giani G., and Berger M. Incidence of blindness in southern Germany between 1990 and 1998. Diabetologia 44 (2001) 147-150
12. Handelman G.J., Dratz E.A., Reay C.C., and Van Kuijk J.G. Carotenoids in the human macula and whole retina. Invest. Ophthalmol. Vis. Sci. 29 (1988) 850-855
13. Richard M.J., Guiraud P., Meo J., and Favier A. High performance liquid chromatography separation of malondialdehyde thiobarbituric acid adduct in biological materials (plasma and human cell) using a commercially available reagent. J. Chromatogr. 577 (1992) 9-18
14. Romero M.J., Bosch-Morell F., Romero B., Rodrigo J.M., Serra M.A., and Romero F.J. Serum malondialdehyde: possible use for the clinical management of chronic hepatitis C patients. Free Radical Biol. Med. 25 (1998) 993-997
15. Lawrence R.A., Parkhill L.K., and Burk R.F. Hepatic cytosolic non-selenium dependent glutathione peroxidase activity: its nature and the effect of selenium deficiency. J. Nutr. 108 (1978) 981-987
16. Reed D.J., Babson J.R., Beatty P.W., Brodie A.E., Ellis W.W., and Potter D.W. High-performance liquid chromatography analysis of nanomole levels of glutathione, glutathione disulfide, and related thiols and disulfides. Anal. Biochem. 106 (1980) 55-62
17. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
18. Morris R.G., Garrud P., Rawlins J.N., and O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature 24 (1982) 681-683
19. Alexander G., Carlsen H., and Blomhoff R. Strong in vivo activation of NF-kappaB in mouse lenses by classic stressors. Invest. Ophthalmol. Vis. Sci. 44 (2003) 2683-2688
20. Halliwell B. Oxidative stress markers in human disease: application to diabetes and to evaluation of the effects of antioxidants. In: Packer L., Rösen P., Tritschler H.J., King G.L., and Azzi A. (Eds). Antioxidants in Diabetes Management (2000), Dekker, New York 33-62
21. Biessels G.J., Van der Heide L.P., Kamal A., Bleys R.L., and Gispen W.H. Ageing and diabetes: implications for brain function. Eur. J. Pharmacol. 441 (2002) 1-14
22. Li Z.G., Zhang W., Grunberger G., and Sima A.A. Hippocampal neuronal apoptosis in type 1 diabetes. Brain Res. 946 (2002) 221-231
23. Miranda M., Muriach M., Johnsen S., Bosch-Morell F., Araiz J., Roma J., and Romero F.J. Oxidative stress in a model for experimental diabetic retinopathy: treatment with antioxidants. Arch. Soc. Esp. Oftalmol. 79 (2004) 289-294
24. Miranda M., Muriach M., Romá J., Bosch-Morell F., Genovés J.M., Barcia J., Araiz J., Diaz-Llopis M., and Romero F.J. Oxidative stress in a model of experimental diabetic retinopathy. II. Peroxynitrites scavengers utility. Arch. Soc. Esp. Oftalmol. 80 (2006) 27-32
25. Clemens J.A., Stephenson D.T., Smalstig E.B., Dixon E.P., and Little S.P. Global ischemia activates nuclear factor-kappa B in forebrain neurons of rats. Stroke 28 (1997) 1073-1080
26. Barber A.J., Lieth E., Khin S.A., Antonetti D.A., Buchanan A.G., and Gardner T.W. The Penn State Research Group. Neural apoptosis in the retina during experimental and human diabetes. J. Clin. Invest. 102 (1998) 783-791
27. Cellek S., Qu W., Schmidt A.M., and Moncada S. Synergistic action of advanced glycation end products and endogenous nitric oxide leads to neuronal apoptosis in vitro: a new insight into selective nitrergic neuropathy in diabetes. Diabetologia 47 (2004) 331-339
28. Cowell R.M., and Russell J.W. Nitrosative injury and antioxidant therapy in the management of diabetic neuropathy. J. Invest. Med. 52 (2004) 33-44
29. Chew B.P., Brown C.M., Park J.S., and Mixter P.F. Dietary lutein inhibits mouse mammary tumor growth by regulating angiogenesis and apoptosis. Anticancer Res. 23 (2003) 3333-3339
30. Panasenko O.M., Sharov V.S., Briviba K., and Sies H. Interaction of peroxynitrite with carotenoids in human low density lipoproteins. Arch. Biochem. Biophys. 373 (2000) 302-305